Chemotherapy-induced Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer [Phase 3]
A Phase 3 study evaluating romiplostim for chemotherapy-induced thrombocytopenia in adults with non-small cell lung cancer, ovarian cancer, …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of hetrombopag to prevent chemotherapy-induced thrombocytopenia in patients with…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Single Arm Romiplostim to Prevent CIT [EARLY_Phase 1]
A single-arm Phase 1 trial is evaluating romiplostim to prevent chemotherapy-induced thrombocytopenia in patients with Ewing sarcoma.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Avatrombopag vs. Placebo for CIT in GI Malignancies [Phase 2]
Phase 2 clinical trial comparing avatrombopag to placebo for chemotherapy-induced thrombocytopenia in gastrointestinal cancers; the study is…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy [Phase 2]
Phase 2 clinical trial update investigating hetrombopag for chemotherapy-induced thrombocytopenia caused by gynecological tumor therapy; not…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer [Phase 3]
Phase 3 clinical trial update on romiplostim for chemotherapy-induced thrombocytopenia in adults with gastrointestinal, pancreatic, or color…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II
This clinical trial is evaluating whether combining thrombopoietin (TPO) with TPORA can improve outcomes for patients with chemotherapy-indu…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia [Phase 3]
Phase 3 clinical trial to evaluate the efficacy and safety of hetrombopag olamine tablets versus placebo in patients with chemotherapy-induc…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 clinical study is evaluating hetrombopag for preventing chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma patients…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study [Phase 2]
Phase 2 exploratory trial evaluating hetrombopag to prevent chemotherapy-induced thrombocytopenia in breast cancer patients, conducted in du…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors [NA]
This clinical trials entry describes a multicenter, open-label randomized study evaluating Romiplostim N01 for chemotherapy- or chemoradioth…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) [Phase 1]
A Phase 1 clinical trial evaluating SCB-219M for chemotherapy-induced thrombocytopenia is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Romiplostim N01 for Chemotherapy-induced Thrombocytopenia [Phase 2]
A Phase 2 clinical trial in China is recruiting to evaluate Romiplostim N01 for chemotherapy-induced thrombocytopenia.
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients [Phase 2]
Phase 2 clinical trial update on Romiplostim (N01) for chemotherapy-induced thrombocytopenia in pediatric cancer patients; the study is curr…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy. [Phase 3]
A Phase 3 trial evaluating hetrombopag for chemotherapy-induced thrombocytopenia in patients with malignancy has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors. [Phase 3]
Ongoing Phase 3 trial evaluating hetrombopag for chemotherapy-induced thrombocytopenia in adults with solid tumors; the study is currently a…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: A Study of PN20 in Healthy Adult Volunteers [Phase 1]
Phase 1 study of PN20 in healthy adult volunteers has been completed; the trial investigated dosing in conditions including chemotherapy-ind…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Herombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]
A Phase 2 clinical trial is recruiting in China to evaluate Herombopag for chemotherapy-induced thrombocytopenia.
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Avatrombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial evaluating avatrombopag for chemotherapy-induced thrombocytopenia is currently recruiting in China.
-
CLINICAL_TRIALS other · 2025-02-24Clinical Trial Update: Eltrombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]
This clinical trial update indicates a Phase 2 study evaluating eltrombopag for chemotherapy-induced thrombocytopenia is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Study of Romiplostim for Chemotherapy Induced Thrombocytopenia [Phase 2]
Phase 2 trial of romiplostim for chemotherapy-induced thrombocytopenia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia [Phase 2, Phase 3]
The document presents a Phase 2/3 clinical trial evaluating the efficacy and safety of QL0911 for preventing chemotherapy-induced thrombocyt…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin [Phase 3]
A Phase 3 randomized trial comparing Romiplostim N01 to recombinant human thrombopoietin for refractory chemotherapy-induced thrombocytopeni…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Romiplostim in Chemotherapy-Induced Thrombocytopenia [Phase 3]
Phase 3 clinical trial update for romiplostim in chemotherapy-induced thrombocytopenia associated with solid malignancies.
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating hetrombopag for secondary prevention of chemotherapy-induced thrombocytopenia in patients with gynecologic…